Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Organoids and Spheroids Market Size, Trends, Analysis, and Outlook Organoids By Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Others), Organoids By Method (General Submerged Method for Organoid Culture, Crypt Organoid Culture Techniques, Air Liquid Interface (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), Spheroids By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others), Spheroids By Source (Cell Line, Primary Cell, iPSCs Derived Cells), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing), By End-user (Biotechnology and pharmaceutical industries, Academic & Research Institutes, Hospitals and diagnostic cente
... (ALI) Method for Organoid Culture, Clonal Organoids from Lgr5+ Cells, Brain and Retina Organoid Formation Protocol, Organoids By Source (Primary Tissues, Stem Cells), Spheroids By Type (Multicellular tumor spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid bodies), ... Read More
-
Adeno Associated Virus Vector Manufacturing Market Size, Trends, Analysis, and Outlook By Scale of Operations (Clinical, Preclinical, Commercial), By Therapeutic Area (Hematological Diseases, Infectious Diseases, Genetic Disorders, Neurological Disorders, Ophthalmic Disorders, Others), By Application (Cell Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030
... Therapy, Gene Therapy, Vaccine), By Method (In Vitro, In Vivo), by Region, Country, Segment, and Companies, 2024-2030 The global Adeno Associated Virus Vector Manufacturing market size is poised to register 23.77% growth from 2024 to ... Read More
-
Advanced Therapy Medicinal Products CDMO Market Size, Trends, Analysis, and Outlook By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Central nervous system, Musculoskeletal, Infectious disease, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030
... nervous system, Musculoskeletal, Infectious disease, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Advanced Therapy Medicinal Products CDMO market size is poised to ... Read More
-
Cell and Gene Therapy Clinical Trials Market Size, Trends, Analysis, and Outlook By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious diseases, Dermatology, Endocrine, metabolic, genetic, Immunology & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030
... & inflammation, Ophthalmology, Hematology, Gastroenterology, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Clinical Trials market size is poised to register 17.85% growth from 2024 to 2030, presenting significant ... Read More
-
CAR T Cell Therapy Market Size, Trends, Analysis, and Outlook By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others), By Disease Indication, Leukemia, Lymphoma, Multiple Myeloma, Others), By End-User (Hospitals, Cancer Treatment Centers), by Region, Country, Segment, and Companies, 2024-2030
... Multiple Myeloma, Others), By End-User (Hospitals, Cancer Treatment Centers), by Region, Country, Segment, and Companies, 2024-2030 The global CAR T Cell Therapy market size is poised to register 25.5% growth from 2024 to 2030, presenting ... Read More
-
Hair Restoration Market Size, Trends, Analysis, and Outlook By Recipient Area(Scalp, Non-scalp), By Treatment (Follicular Unit Extraction (FUE), Follicular Unit Transplant (FUT), Laser Therapy, Stem Cell Therapy, Others), By End-User (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Hair Restoration market size is poised to register 14.49% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Allogeneic Cell Therapy Market Size, Trends, Analysis, and Outlook By Type (Stem Cell Therapies, Hematopoietic Stem Cell Therapies, Mesenchymal Stem Cell Therapies, Non-stem Cell Therapies, Keratinocytes & Fibroblast-based Therapies, Others), By Therapeutic Area (Hematological Disorders, Dermatological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Dermatological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Allogeneic Cell Therapy market size is poised to register 26.62% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Cell Therapy Market Size, Trends, Analysis, and Outlook By Type (Allogeneic Therapies, Autologous Therapies, Cell Therapeutic Area, Oncology, Cardiovascular Disease (CVD), Musculoskeletal Disorders, Dermatology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Therapy market size is poised to register 21.02% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cell Therapy market across By Type ... Read More
-
Upstream Bioprocessing Market Size, Trends, Analysis, and Outlook By Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers, Others), By Workflow (Media Preparation, Cell Culture, Cell Separation), By Use Type, Multi-Use, Single-Use), By Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030
... Mode (In-House, Outsourced), by Region, Country, Segment, and Companies, 2024-2030 The global Upstream Bioprocessing market size is poised to register 16.38% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Biobank Market Size, Trends, Analysis, and Outlook By Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems), By Service (Biobanking & Repository, Lab processing, Qualification/ Validation, Cold Chain Logistics, Others), By Biospecimen Type (Human Tissues, Organs, Stem Cells, Others), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others), by Region, Country, Segment, and Companies, 2024-2030
... Organs, Stem Cells, Others), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Biobank market size is poised ... Read More
-
Cord Blood Banking Services Market Size, Trends, Analysis, and Outlook By Bank (Private, Public, Hybrid), By Application (Leukaemia, Genetic Disorders, Immune Deficiencies, Others), by Region, Country, Segment, and Companies, 2024-2030
... Services market size is poised to register 10.61% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cord Blood Banking Services market across ... Read More
-
Global Stem Cell Assay Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Stem Cell Assay is forecast to a readjusted size of US$ 1749.2 million by 2030 with a CAGR of 11.8% during review period. The research report highlights the growth potential ... Read More
-
The 2025-2030 World Outlook for Stem Cell Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Stem Cell Technologies and Applications
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Stem Cells
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Stem Cell Banking
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Cell Harvesting
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Longevity and Anti-Senescence Therapies
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Human Embryonic Stem Cells
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Induced Pluripotent Stem Cells
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Stem Cell Products
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Stem Cell and Regenerative Medicines
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Stem Cell Assay Viability and Cytotoxicity
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Stem Cell Line Manufacturing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Stem Cell Services
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More